Diane Kleinermans | Dr
Belgian Federal Government

Diane Kleinermans, Dr, Belgian Federal Government

Diane Kleinermans works as advisor to the Minister of Public Health and Social Affairs since 2015. She is responsible of dossiers related to clinical trials. Diane has a medical background and a broad experience in various fields. She started her career as GP in Brussels but rapidly collaborated with the pharmaceutical industry. Her first employer was Pfizer where she stayed for more than 15 years, working in early development and creating their Phase I Unit in Erasme which she managed for 10 years, She then left Belgium and worked as medical director of CRO’s in France and the UK, before joining Novartis Ophthalmics as head of the scientists group in Zurich. She then came back to Belgium where, after a short experience in the regulatory department of GSK Biologicals, she joined the NIHDI as internal expert to the Commission of Drugs reimbursement, being amongst others in charge of orphan drugs assessments.


World Orphan Drug Congress USA 2018 - Conference Day One @ 12:15

BENELUXA Belgium, Netherlands, Luxembourg and Austria joining forces to improve access and to orphan drugs and paving the way for more collaborations

  • Joint collaboration to negotiate with pharmaceutical companies the price of orphan drugs
  • Looking into data exchange, sharing of registries and coordinated assessment of new technologies and innovation 
  • Advantages in patient access and dossier submission for pharmaceutical companies 

back to speakers